Dr. Reljanovic founded Ergomed and has been instrumental in shaping the company’s strategy, values, and longterm direction since its inception. Under his leadership, Ergomed has grown into a global organisation with a strong reputation for quality, governance, and client service. The Board extends its sincere gratitude to Dr. Reljanovic for his outstanding contribution and legacy.
Andy Eckert brings deep experience in healthcare, life sciences, and technologyenabled services, having served in senior executive and Board Chair roles across global organisations. Mr. Eckert’s insights, and extensive background in healthcare, will be an asset as the Board supports the executive leadership team’s efforts to drive differentiation that will advance each brand’s market position.
He has worked closely with Permira, Ergomed’s majority shareholder, as a Senior Advisor since 2022. As Chair, Andy will focus on strong governance, strategic oversight, and supporting the management team as Ergomed Group continues to execute its strategy.
